Advanced Container Technologies Inc (ACOL) Inventory Turnover Ratio, from third quarter 2022 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Advanced Container Technologies Inc   (ACOL)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Advanced Container Technologies Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2022, Advanced Container Technologies Inc 's inventory turnover ratio sequentially decreased to 6.57 in the third quarter 2022, unsurprisingly, as the Advanced Container Technologies Inc markets continue to deteriorate, and ACOL's faces growing challenges to bring down its inventories. Advanced Container Technologies Inc 's average inventory processing period in the Sep 30 2022 quarter, has increased to 56 days, from 44 days, in the Jun 30 2022 quarter.

Within Healthcare sector 63 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 359 in the second quarter 2022, to 474.

ACOL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Advanced Container Technologies Inc Market Share?

What is Inventory Turnover Ratio?




ACOL Inventory Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Inventory Growth 22.58 % 37.37 % 33.15 % 315.12 % 141.12 %
Y / Y Cost of Sales Growth -54.11 % 8.2 % -60.78 % 159.8 % 203.96 %
Inventory Turnover Ratio (TTM) 6.57 8.34 8.89 12.17 13.34
ACOL's Total Ranking # 474 # 359 # 337 # 355 #
Average inventory processing period 56 44 41 30 27
Seq. Inventory Growth 4.96 % 19.95 % -17.7 % 18.31 % 17.62 %
Seq. Cost of Sales Growth -8.5 % -12.47 % -46.67 % 7.44 % 115.76 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 11
Healthcare Sector # 64
Overall Market # 474

Inventory Turnover Ratio Statistics
High Average Low
19.8 8.96 3.15
(Mar 31 2019)   (Sep 30 2017)




Financial Statements
Advanced Container Technologies Inc 's Inventories $ 0 Millions Visit ACOL's Balance sheet
Advanced Container Technologies Inc 's Cost of Revenues TTM $ 3 Millions Visit ACOL's Income Statement
What are ACOL's Sales? Visit ACOL's Sales by Segment

Other Inventory Turnover Ratios
Advanced Container Technologies Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ACOL's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ACOL's Competitors
Inventory Turnover Ratio for ACOL's Suppliers
Inventory Turnover Ratio for ACOL's Customers

You may also want to know
ACOL's Sales Growth Rates ACOL's Pe Price to earnings ratio ACOL's Receivables Turnover Ratio ACOL's Stock Quote
ACOL's Net Income Growth Rates ACOL's Ps Price to Sales ratio ACOL's Sales per Employee ACOL's Asset Turnover Ratio
ACOL's Net Margin ACOL's Pb Price to Book ratio ACOL's Financial Strength Ratios ACOL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2022 Inventories at quarter ending Sep 30 2022
Biocept Inc   14.03 $ 35.138  Millions$ 3  Millions
Option Care Health Inc   13.81 $ 2,996.682  Millions$ 217  Millions
Natera Inc   13.53 $ 415.522  Millions$ 31  Millions
Rockwell Medical inc   13.38 $ 66.212  Millions$ 5  Millions
Dermtech Inc   13.34 $ 13.561  Millions$ 1  Millions
Prophase Labs Inc   13.26 $ 61.992  Millions$ 5  Millions
23andme Holding Co  12.00 $ 159.539  Millions$ 13  Millions
Myriad Genetics Inc   11.77 $ 193.900  Millions$ 16  Millions
Dmk Pharmaceuticals Corporation  11.69 $ 5.795  Millions$ 0  Millions
Precipio inc   11.54 $ 6.899  Millions$ 1  Millions
Rvl Pharmaceuticals Plc  11.30 $ 7.979  Millions$ 1  Millions
Invitae Corporation  10.79 $ 420.518  Millions$ 39  Millions
Sunlink Health Systems Inc   10.48 $ 19.403  Millions$ 2  Millions
Infusystem Holdings Inc  10.44 $ 45.803  Millions$ 4  Millions
Clene Inc   10.16 $ 0.569  Millions$ 0  Millions
Sotera Health Company  10.05 $ 444.109  Millions$ 44  Millions
Cryo cell International Inc   9.83 $ 8.949  Millions$ 1  Millions
Irhythm Holdings Inc   9.76 $ 125.900  Millions$ 13  Millions
Semler Scientific inc   9.61 $ 5.236  Millions$ 1  Millions
Eton Pharmaceuticals Inc   9.54 $ 4.944  Millions$ 1  Millions
Lantheus Holdings Inc   9.53 $ 329.017  Millions$ 35  Millions
Castle Biosciences Inc   9.39 $ 27.086  Millions$ 3  Millions
Cardiff Lexington Corporation  9.32 $ 5.033  Millions$ 1  Millions
Opko Health Inc   9.31 $ 792.963  Millions$ 85  Millions
Genedx Holdings Corp   9.10 $ 353.813  Millions$ 39  Millions
Qhslab Inc   8.91 $ 0.648  Millions$ 0  Millions
Nutriband Inc   8.72 $ 1.320  Millions$ 0  Millions
Agile Therapeutics Inc  8.66 $ 16.884  Millions$ 2  Millions
Charles River Laboratories International inc   8.56 $ 2,008.284  Millions$ 235  Millions
Universe Pharmaceuticals Inc  8.27 $ 18.252  Millions$ 2  Millions

Date modified: 2026-06-22T11:02:49+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.